Blood-based neurochemical diagnosis of vascular dementia: a pilot study-Reference-Cited by-同舟云学术

Blood-based neurochemical diagnosis of vascular dementia: a pilot study

Published:2007-07-27 Issue:2 Volume:103 Page:467-474
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Bibl Mirko,Esselmann Hermann,Mollenhauer Brit,Weniger Godehard,Welge Volker,Liess Michael,Lewczuk Piotr,Otto Markus,Schulz Jörg B,Trenkwalder Claudia,Kornhuber Johannes,Wiltfang Jens

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2007.04763.x/fullpdf

Reference30 articles.

1. Cerebrospinal fluid (CSF) amyloid beta (Aβ) peptide patterns in Alzheimer’s disease (AD) patients and non-demented controls depend on sample pre-treatment: Indication of carrier- mediated epitope masking of Aβ peptides;Bibl;Electrophoresis,2004

2. CSF amyloid-β-peptides in Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease dementia;Bibl;Brain,2006

3. Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias;Bibl;Mol. Psy,2007

4. Cerebrospinal Fluid Protein Biomarkers for Alzheimer’s disease;Blennow;NeuroRX,2004

5. Prospective neuropathological validation of Hachinski’s ischaemic score in dementias;Fischer;J. Neurol. Neurosurg. Psychiatry,1991

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Diagnostic Value of Electrovestibulography (EVestG) in Alzheimer’s Patients with Mixed Pathology: A Pilot Study;Medicina;2023-11-28

2. Unravelling the Threads: A Brief Insight into Vascular Dementia;Journal of Vascular Diseases;2023-11-02

3. Altered serum amyloid beta and cerebral perfusion and their associations with cognitive function in patients with subcortical ischemic vascular disease;Frontiers in Neuroscience;2022-10-13

4. Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview;Current Pharmaceutical Design;2022-04

5. Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease;Alzheimer's & Dementia;2022-03-12